BioCentury

8:00 AM GMT, Feb 28, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

FT1050: Preliminary Phase Ib data

Preliminary data from an open-label, U.S. Phase Ib trial in 15 evaluable patients with hematologic malignancies who have undergone non-myeloablative conditioning therapy showed that dual umbilical cord blood

Read the full 281 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.